MIYAMOTO SATOSHI 宮本聡

… Alternative Names

MIYAMOTO Satoshi 宮本聡

Less

Researcher Number	60779429
Other IDs
Affiliation (Current)	2026: 岡山大学, 医療開発領域, 講師
Affiliation (based on the past Project Information) *help	2017 – 2024: 岡山大学, 大学病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 53040:Nephrology-related Except Principal Investigator Basic Section 53040:Nephrology-related / Kidney internal medicine
Keywords	Principal Investigator IL-18 / 糖尿病性腎臓病 / 質量分析イメージング / 糖尿病性腎症 Except Principal Investigator インフラマソーム / 糖尿病性腎症 / 炎症

糖尿病性腎臓病におけるIL-18によるインフラマソーム活性化機構の解明と治療応用Principal Investigator
- Principal Investigator
  
  宮本聡
- Project Period (FY)
  2022 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53040:Nephrology-related
- Research Institution
  Okayama University
Development of the new therapeutic strategy for diabetic nephropathy by modulation of inflammasome.
- Principal Investigator
  
  Kenichi Shikata
- Project Period (FY)
  2020 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53040:Nephrology-related
- Research Institution
  Okayama University
Exploration of Therapeutic Targets for Diabetic Kidney Disease Using Spacial Omics-Based ApproachPrincipal Investigator
- Principal Investigator
  
  MIYAMOTO Satoshi
- Project Period (FY)
  2018 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53040:Nephrology-related
- Research Institution
  Okayama University
Development of new therapeutic strategy by targeting the inflammasome.
- Principal Investigator
  
  Shikata Kenichi
- Project Period (FY)
  2017 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Kidney internal medicine
- Research Institution
  Okayama University

All 2025 2024 2023 2022 2021 2020 2019 2018 2017

All Journal Article Presentation Book

[Book] 糖尿病最新の治療2025-2027（執筆担当：Ⅵ 糖尿病性腎症 3. 顕性アルブミン尿期（第３期））2025
- Author(s)
  宮本聡、四方賢一
- Total Pages
  352
- Publisher
  南江堂
- ISBN
  9784524211449
- Data Source
  KAKENHI-PROJECT-18K08211
[Book] Glycemic Control and Future Perspectives for Treatment. In: Wada T., Furuichi K., Kashihara N. (eds) Diabetic Kidney Disease.2021
- Author(s)
  Miyamoto S., Shikata K
- Total Pages
  190
- Publisher
  Springer
- ISBN
  9789811593017
- Data Source
  KAKENHI-PROJECT-20K08635
[Book] CKD療養ガイド20182018
- Author(s)
  岡田浩一，安田宣成，柏原直樹，旭浩一，伊藤孝史, 要伸也, 神田英一郎, 菅野義彦, 四方賢一, 柴垣有吾, 土谷健, 鶴屋和彦, 長田太助, 成田一衛, 南学正臣, 服部元史, 濱野高行, 藤元昭一, 守山敏樹, 山縣邦弘，宮本聡，他
- Total Pages
  119
- Publisher
  東京医学社
- ISBN
  9784885637049
- Data Source
  KAKENHI-PROJECT-17K09698
[Book] 糖尿病性腎臓病の診かた、考えかた2018
- Author(s)
  和田隆志，柏原直樹，古市賢吾，湯澤由紀夫，稲熊大城，高橋和男，伊藤衣里，秋山真一，久米真司，鈴木芳樹，宮本　聡，四方賢一，小田香織，利根淳仁，梶谷展生，大西章史，杉山　斉，遠山直志，徳丸季聡
- Total Pages
  223
- Publisher
  中外医学社
- ISBN
  9784498224360
- Data Source
  KAKENHI-PROJECT-17K09698
[Journal Article] A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope2024
- Author(s)
  Miyamoto Satoshi、Heerspink Hiddo J.L.、de Zeeuw Dick、Sakamoto Kota、Yoshida Michihiro、Toyoda Masao、Suzuki Daisuke、Hatanaka Takashi、Nakamura Tohru、Kamei Shinji、Murao Satoshi、Hida Kazuyuki、Ando Shinichiro、Akai Hiroaki、Takahashi Yasushi、Kitada Munehiro、Sugano Hisashi、Nunoue Tomokazu、Nakamura Akihiko et al.
- Journal Title
  
  Kidney International
  
  Volume: 106 Issue: 5 Pages: 972-984
- DOI
  10.1016/j.kint.2024.08.019
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08211, KAKENHI-PROJECT-22K08347
[Journal Article] Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3)2024
- Author(s)
  Ueno Asami、Wada Jun
- Journal Title
  
  BMJ Open Diabetes Research & Care
  
  Volume: 12 Issue: 3 Pages: e004237-e004237
- DOI
  10.1136/bmjdrc-2024-004237
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K24349, KAKENHI-PROJECT-18K08211, KAKENHI-PROJECT-23K07673, KAKENHI-PROJECT-24K11410
[Journal Article] Suramin prevents the development of diabetic kidney disease by inhibiting NLRP3 inflammasome activation in KK-Ay mice2023
- Author(s)
  Oda K, Miyamoto S, Kodera R, Wada J, Shikata K.
- Journal Title
  
  J Diabetes Investig.
  
  Volume: 14 Issue: 2 Pages: 205-220
- DOI
  10.1111/jdi.13930
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08635
[Journal Article] Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study2022
- Author(s)
  Miyamoto S, Heerspink HJL, de Zeeuw D, Toyoda M, Suzuki D, Hatanaka T, Nakamura T, Kamei S, Murao S, Hida K, Ando S, Akai H, Takahashi Y, Koya D, Kitada M, Sugano H, Nunoue T, Nakamura A, Sasaki M, Nakatou T, Fujimoto K, Kawanami D, Wada T, Miyatake N, Yoshida M, Shikata K; CANPIONE study Investigators.
- Journal Title
  
  Diabetes Obes Metab
  
  Volume: 24 Issue: 8 Pages: 1429-1438
- DOI
  10.1111/dom.14731
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K21773, KAKENHI-PROJECT-20K08635
[Journal Article] Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan)2021
- Author(s)
  Shikata K, Haneda M, Ninomiya T, Koya D, Suzuki Y, Suzuki D, Ishida H, Akai H, Tomino Y, Uzu T, Nishimura M, Maeda S, Ogawa D, Miyamoto S, Makino H; Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan) collaborative group.
- Journal Title
  
  J Diabetes Investig.
  
  Volume: 12 Issue: 2 Pages: 207-216
- DOI
  10.1111/jdi.13339
- NAID
  120006880216
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K21773, KAKENHI-PROJECT-17K09698, KAKENHI-PROJECT-20K08635
[Journal Article] Novel Urinary Glycan Biomarkers Predict Cardiovascular Events in Patients With Type 2 Diabetes: A Multicenter Prospective Study With 5-Year Follow Up (U-CARE Study 2).2021
- Author(s)
  Mise K, Imamura M, Yamaguchi S, Watanabe M, Higuchi C, Katayama A, Miyamoto S, Uchida HA, Nakatsuka A, Eguchi J, Hida K, Nakato T, Tone A, Teshigawara S, Matsuoka T, Kamei S, Murakami K, Shimizu I, Miyashita K, Ando S, Nunoue T, Yoshida M, Yamada M, Shikata K, Wada J.
- Journal Title
  
  Front Cardiovasc Med.
  
  Volume: 8 Pages: 668059-668059
- DOI
  10.3389/fcvm.2021.668059
- NAID
  120007053373
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03675, KAKENHI-PROJECT-20K08608, KAKENHI-PROJECT-20K08635
[Journal Article] Dysfunction of CD8 + PD-1 + T cells in type 2 diabetes caused by the impairment of metabolism-immune axis2020
- Author(s)
  Nojima I, Eikawa S, Tomonobu N, Hada Y, Kajitani N, Teshigawara S, Miyamoto S, Tone A, Uchida HA, Nakatsuka A, Eguchi J, Shikata K, Udono H, Wada J.
- Journal Title
  
  Sci Rep.
  
  Volume: 10 Issue: 1 Pages: 14928-14928
- DOI
  10.1038/s41598-020-71946-3
- NAID
  120006891215
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08608, KAKENHI-PROJECT-20K08908, KAKENHI-PROJECT-18H04033, KAKENHI-PROJECT-19H03675, KAKENHI-PROJECT-17K09698, KAKENHI-PROJECT-20K08635
[Journal Article] Prevalence of albuminuria and renal dysfunction, and related clinical factors in Japanese patients with diabetes: The Japan Diabetes Complication and its Prevention prospective study 52020
- Author(s)
  Shikata K, Kodera R, Utsunomiya K, Koya D, Nishimura R, Miyamoto S, Tajima N; JDCP study group.
- Journal Title
  
  J Diabetes Investig .
  
  Volume: 11 Issue: 2 Pages: 325-332
- DOI
  10.1111/jdi.13116
- NAID
  120007004813
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K21773, KAKENHI-PROJECT-17K09698
[Journal Article] Gut Microbial Changes in Diabetic db/db Mice and Recovery of Microbial Diversity upon Pirfenidone Treatment2020
- Author(s)
  Singh Harinder、Miyamoto Satoshi、Darshi Manjula、Torralba Manolito G.、Kwon Keehwan、Sharma Kumar、Pieper Rembert
- Journal Title
  
  Microorganisms
  
  Volume: 8 Issue: 9 Pages: 1347-1347
- DOI
  10.3390/microorganisms8091347
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09698, KAKENHI-PROJECT-20K08635
[Journal Article] 糖尿病性腎臓病の新規治療標的の探索　～炎症を標的とした治療戦略～2020
- Author(s)
  宮本聡、四方賢一
- Journal Title
  
  糖尿病合併症
  
  Volume: 34 Pages: 295-297
- Data Source
  KAKENHI-PROJECT-20K08635
[Journal Article] SGLT2阻害薬の腎保護効果（大規模臨床試験を中心に）2020
- Author(s)
  宮本　聡、和田　淳
- Journal Title
  
  腎臓内科
  
  Volume: 11 Pages: 1-8
- Data Source
  KAKENHI-PROJECT-17K09698
[Journal Article] 糖尿病性腎臓病（DKD）：保存期2020
- Author(s)
  宮本聡、木野村賢、四方賢一
- Journal Title
  
  腎と透析
  
  Volume: 88 Pages: 60-64
- Data Source
  KAKENHI-PROJECT-20K08635
[Journal Article] The hypoglycemia-prevention effect of sensor-augmented pump therapy with predictive low glucose management in Japanese patients with type 1 diabetes mellitus: a short-term study.2019
- Author(s)
  Katayama A, Tone A, Watanabe M, Teshigawara S, Miyamoto S, Eguchi J, Nakatsuka A, Shikata K, Wada J.
- Journal Title
  
  Diabetol Int.
  
  Volume: 11(2) Issue: 2 Pages: 97-104
- DOI
  10.1007/s13340-019-00408-7
- NAID
  120006884491
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09861, KAKENHI-PROJECT-17K09698
[Journal Article] SGLT2阻害薬の腎保護効果2018
- Author(s)
  宮本　聡、和田　淳
- Journal Title
  
  月刊糖尿病
  
  Volume: 10 Pages: 67-74
- Data Source
  KAKENHI-PROJECT-17K09698
[Journal Article] エビデンスに基づくCKD診療ガイドライン20182018
- Author(s)
  岡田浩一, 安田宜成, 柏原　直樹，旭浩一, 伊藤孝史, 要伸也, 神田英一郎, 菅野義彦, 四方賢一, 柴垣有吾, 土谷健, 鶴屋和彦, 長田太助, 成田一衛, 南学正臣, 服部元史, 濱野高行, 藤元昭一, 守山敏樹, 山縣邦弘，宮本聡，他
- Journal Title
  
  日本腎臓学会誌
  
  Volume: 60 Pages: 1037-1193
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09698
[Journal Article] SGLT2阻害薬の腎保護作用2018
- Author(s)
  宮本　聡、和田　淳
- Journal Title
  
  腎臓内科・泌尿器科
  
  Volume: 8 Pages: 297-303
- Data Source
  KAKENHI-PROJECT-17K09698
[Journal Article] Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 20182018
- Author(s)
  Japanese Society of Nephrology
- Journal Title
  
  Clinical and Experimental Nephrology
  
  Volume: 23 Issue: 1 Pages: 1-15
- DOI
  10.1007/s10157-018-1648-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09688, KAKENHI-PROJECT-18K19716, KAKENHI-PROJECT-17K09698
[Journal Article] 慢性炎症と糖尿病腎症2017
- Author(s)
  宮本聡、四方賢一、和田淳
- Journal Title
  
  糖尿病診療マスター
  
  Volume: 15 Pages: 856-861
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] 糖尿病治療薬と腎症　～残余リスクのさらなる軽減のために～2024
- Author(s)
  宮本聡、Hiddo J.L. Heerspink、Dick de Zeeuw、四方賢一
- Organizer
  第39回日本糖尿病合併症学会
- Invited
- Data Source
  KAKENHI-PROJECT-18K08211
[Presentation] 微量アルブミン尿期のSGLT2阻害薬のエビデンス　～CANPIONE studyの結果を踏まえて～2024
- Author(s)
  宮本聡、Hiddo J.L. Heerspink、Dick de Zeeuw、四方賢一
- Organizer
  第35回日本糖尿病性腎症研究会
- Invited
- Data Source
  KAKENHI-PROJECT-18K08211
[Presentation] The effects of canagliflozin on albuminuria and eGFR decline using an individual preintervention eGFRslope2024
- Author(s)
  Satoshi Miyamoto, Hiddo J. Heerspink, Dick de Zeeuw, Kota Sakamoto, Michihiro Yoshida, Hiromi Kuramoto, Kenichi Shikata
- Organizer
  ASN Kidney Week 2024
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08211
[Presentation] NLRP3 inflammasomeの制御を介した糖尿病マウスにおける糖尿病性腎症の発症・進展抑制効果2023
- Author(s)
  小田香、宮本聡, 和田淳, 四方賢一
- Organizer
  第38回日本糖尿病合併症学会
- Data Source
  KAKENHI-PROJECT-20K08635
[Presentation] NLRP3 inflammasomeの活性化を抑制することによる糖尿病性腎臓病治療の可能性2022
- Author(s)
  小田香織、宮本聡, 小寺亮, 和田淳, 四方賢一
- Organizer
  第37回日本糖尿病合併症学会
- Data Source
  KAKENHI-PROJECT-20K08635
[Presentation] Diabetic kidney disease and inflammation2021
- Author(s)
  宮本聡，四方賢一
- Organizer
  第64回日本糖尿病学会年次学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-20K08635
[Presentation] 当院におけるTime-In-Range（TIR）とHbA1cとの関連についての検討2020
- Author(s)
  片山晶博，野島一郎，樋口千草，渡邉真由，宮本聡，中司敦子，江口潤，四方賢一，和田淳
- Organizer
  第63回日本糖尿病学会年次学術集会
- Data Source
  KAKENHI-PROJECT-20K08635
[Presentation] 治療ターゲットとしてのインフラマゾーム2020
- Author(s)
  宮本聡，四方賢一
- Organizer
  第50回日本腎臓学会西部学術大会
- Invited
- Data Source
  KAKENHI-PROJECT-20K08635
[Presentation] Inflammasomeの制御を介したsuraminによる糖尿病性腎症の進展抑制効果2020
- Author(s)
  小田香織, 宮本聡, 小寺亮, 和田淳, 四方賢一
- Organizer
  第35回日本糖尿病合併症学会
- Data Source
  KAKENHI-PROJECT-20K08635
[Presentation] 幻聴を契機にインスリン5700単位を自己注射し低血糖が遷延した1型糖尿病の1例2020
- Author(s)
  和田嵩平, 宮本聡, 野島一郎, 中島有理, 岡本修吾, 当真貴志雄, 四方賢一, 和田淳
- Organizer
  日本糖尿病学会中国四国地方会第58回総会
- Data Source
  KAKENHI-PROJECT-20K08635
[Presentation] Targeting inflammasome in diabetic kidney disease2020
- Author(s)
  宮本聡，小田香織, 四方賢一
- Organizer
  第63回日本糖尿病学会年次学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-20K08635
[Presentation] 糖尿病性腎臓病の新規治療標的の探索～炎症を標的とした治療戦略～2019
- Author(s)
  宮本聡，四方賢一
- Organizer
  第34回日本糖尿病合併症学会
- Invited
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] 糖尿病マウスにおけるP2X受容体阻害による腎保護効果2019
- Author(s)
  小田香織、宮本聡、小寺亮、和田淳、四方賢一
- Organizer
  第62回日本糖尿病学会年次学術集会
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] JDCP研究が示す我が国の糖尿病診療の現状日本人2型糖尿病患者における腎症の合併率と発症関連因子　JDCP研究データの解析2018
- Author(s)
  四方賢一, 宇都宮一典, 古家大祐, 小寺亮, 宮本聡, 西村理明, 田嶼尚子
- Organizer
  第61回日本糖尿病学会年次学術集会
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] Suramin Inhibits Activation of Inflammasome and Protects against Progression of Diabetic Kidney Disease in KK-Ay Mice2018
- Author(s)
  Oda K, Miyamoto S, Kodera R, Wada J, Shikata K
- Organizer
  ASN Kidney Week 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] 糖尿病性腎症の発症・進展におけるinflammasomeの関与2018
- Author(s)
  小田香織, 宮本聡, 小寺亮, 和田淳, 四方賢一
- Organizer
  第61回日本糖尿病学会年次学術集会
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] 糖尿病腎症の病態解明cutting edge 糖尿病腎症の病態と成因における炎症の意義2018
- Author(s)
  四方賢一, 宮本聡
- Organizer
  第61回日本糖尿病学会年次学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] Inflammasomeの制御を介したP2X受容体阻害薬の糖尿病マウスにおける腎保護効果2018
- Author(s)
  小田香織、宮本聡、小寺亮、和田淳、四方賢一
- Organizer
  第30回糖尿病性腎症研究会
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] P2X受容体の阻害はinflammasomeの制御を介して糖尿病性腎症の発症・進展を抑制する2018
- Author(s)
  小田香織, 宮本聡, 小寺亮, 和田淳, 四方賢一
- Organizer
  第33回日本糖尿病合併症学会
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] Suraminはinflammasomeを制御し糖尿病性腎症の進展を抑制する2017
- Author(s)
  小田　香織、宮本　聡、小寺　亮、和田　淳、四方賢一
- Organizer
  第60回日本糖尿病学会年次学術集会
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] 糖尿病性腎症の成因におけるinflammasomeの関与2017
- Author(s)
  小田　香織、宮本　聡、小寺　亮、和田　淳、四方賢一
- Organizer
  第29回日本糖尿病性腎症研究会
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] Inflammasomeの抑制によるsuraminの糖尿病マウスにおける腎保護効果2017
- Author(s)
  小田　香織、宮本　聡、小寺　亮、和田　淳、四方賢一
- Organizer
  第32回日本糖尿病合併症学会
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] 質量分析イメージングを用いた糖尿病性腎症の病態解明とインフラマソームを標的とした新しい治療戦略2017
- Author(s)
  宮本聡
- Organizer
  第60回日本糖尿病学会年次学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] Inhibiting Inflammasome Activation with Suramin Protects against Progression of Diabetic Kidney Disease in KK-Ay Mice2017
- Author(s)
  Kaori Oda, Satoshi Miyamoto, Ryo Kodera, Jun Wada, Kenichi Shikata
- Organizer
  ASN kidney week 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09698
[Presentation] Mass Spectrometry Imaging in the Diabetic Kidney2017
- Author(s)
  Satoshi Miyamoto
- Organizer
  ASN kidney week 2017
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09698

1. Shikata Kenichi (00243452)

# of Collaborated Projects: 4 results

# of Collaborated Products: 32 results
2. 中司敦子

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
3. 古家大祐

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
4. 和田淳

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
5. 北田宗弘

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

MIYAMOTO SATOSHI 宮本 聡

MIYAMOTO Satoshi 宮本 聡

Research Projects

Research Products

Co-Researchers

糖尿病性腎臓病におけるIL-18によるインフラマソーム活性化機構の解明と治療応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of the new therapeutic strategy for diabetic nephropathy by modulation of inflammasome.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Exploration of Therapeutic Targets for Diabetic Kidney Disease Using Spacial Omics-Based ApproachPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of new therapeutic strategy by targeting the inflammasome.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 糖尿病最新の治療2025-2027（執筆担当：Ⅵ 糖尿病性腎症 3. 顕性アルブミン尿期（第３期））2025

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] Glycemic Control and Future Perspectives for Treatment. In: Wada T., Furuichi K., Kashihara N. (eds) Diabetic Kidney Disease.2021

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] CKD療養ガイド20182018

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] 糖尿病性腎臓病の診かた、考えかた2018

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Journal Article] A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3)2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Suramin prevents the development of diabetic kidney disease by inhibiting NLRP3 inflammasome activation in KK-Ay mice2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan)2021

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Novel Urinary Glycan Biomarkers Predict Cardiovascular Events in Patients With Type 2 Diabetes: A Multicenter Prospective Study With 5-Year Follow Up (U-CARE Study 2).2021

MIYAMOTO SATOSHI 宮本聡

MIYAMOTO Satoshi 宮本聡

[Journal Article] 糖尿病性腎臓病の新規治療標的の探索　～炎症を標的とした治療戦略～2020

[Presentation] 糖尿病治療薬と腎症　～残余リスクのさらなる軽減のために～2024

[Presentation] 微量アルブミン尿期のSGLT2阻害薬のエビデンス　～CANPIONE studyの結果を踏まえて～2024